CLYM: Climb Bio Inc. Kompaniya qiymatining sof foydaga nisbati
Climb Bio Inc (CLYM) kompaniyasiga investitsiya kiritish daromadlilikning yo'qligi va sinovlarning ilk bosqichlarida tashqi moliyalashtirishga bog'liqlik sababli yuqori xatarlarni keltirib chiqaradi. Shunga qaramay, Climb Bio Inc (CLYM) B-hujayralarni bostirish orqali autoimmun patologiyalar uchun kompleks terapiya tizimini ishlab chiqmoqda. Indikator -10.50 qiymatida turgan ushbu grafikdagi tasdiqlangan narxlar tarixi biotexnologiyaning nostsiklilik tabiatini ta'kidlaydi, uning rivojlanishi iqtisodiy sikllardan ko'ra ko'proq tibbiy kashfiyotlarga bog'liqdir.
%20P%2FE%20multiplikatori&width=1200&height=400&colorIndex=0&v=mwa76aez.ocr-7cpmfb4&start=20220704&end=20261110&filename=GURU_Markets_-_CLYM_-_Climb-Bio-Inc_-_PE-Multiple "CLYM: Climb Bio Inc Biznesning o‘zini qoplash muddati 04.10.2024 - 10.11.2026 | 👁️GURU.Markets👁️")
Climb Bio, Inc. (CLYM) kompaniyasining tahliliy kesimlari
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Climb Bio Inc|CLYM - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati Climb Bio, Inc|CLYM - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati Climb Bio Inc.|CLYM - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz Climb Bio|Tezkor likvidlik ko‘rsatkichi climbbio.com
- foyda va bozor multiplikatorlari tafsilotlari:
CLYM - Kompaniyaning sof foydasi|Kutilayotgan foyda Climb Bio Inc|CLYM - P/E multiplikatori|Kapitalizatsiyaning prognoz qilingan foydaga nisbati Climb Bio Inc.|CLYM - Narxning foydaga va o‘sish sur’atiga nisbati|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati koeffitsiyenti Climb Bio Inc.|CLYM - EBITDA operatsion foydasi|So'nggi o'n ikki oy davomida bir aksiya uchun foyda Climb Bio|CLYM - So'nggi 12 oy davomida bir aksiya uchun sof foyda|So'nggi 12 oy davomida bitta aksiya uchun foydaning yillik o'sishi climbbio.com|CLYM - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun sof foyda o'sishi prognozi Climb Bio Inc
Kompaniyaning har tomonlama tahlili:climbbio.com CLYM
P/E koeffitsiyenti sof foydaning bir birligining bozor qiymatini belgilaydi va investitsiyaning qoplash muddatini o'lchaydi. Investorlar aktivning haqiqiy daromadlariga nisbatan haddan tashqari qimmat baholanganligini aniqlash uchun ushbu koeffitsiyentdan foydalanadilar. Kompaniyaning median P/E koeffitsiyentini tahlil qilish orqali uning kapitalizatsiyasining bozor zarbalariga chidamliligini baholash mumkin. Climb Bio Inc (CLYM) uchun ishlab chiqarishni autsorsing qilish natijasida kamaygan kapital xarajatlar ushbu metrikan intellektual kapitalni boshqarish samaradorligining asosiy ko'rsatkichiga aylantiradi.
Muhim raqobatchilar
P/E multiplikatori argenx.com|Narx-foyda koeffitsiyenti BNTX (BioNTech)|ABVX (ABIVAX) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ADMA (ADMA Bio)|Biznesning o‘zini qoplash muddati Protagonist Corp (PTGX)|IMVT - Narxning foydaga nisbati|kiniksa.com (KNSA) - Narx-foyda koeffitsiyenti|Grifols (GRFS) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Adaptive Biotech|Narx-foyda koeffitsiyenti CLDX|P/E multiplikatori Aurinia Corp|Narxning foydaga nisbati BioCryst (BCRX)|veratx.com - Narx-foyda multiplikatori|P/E multiplikatori DNTH (Dianthus Therapeutics, Inc.)|Pharvaris NV (PHVS) - Kapitalizatsiyaning foydaga nisbati|AbCellera Bio - P/E multiplikatori|Tourmaline (TRML) - Narx-foyda koeffitsiyenti|Precigen, Inc. (PGEN) - Narxning foydaga nisbati|PHAR (pharming.com) - Narxning foydaga nisbati|NKTR (Nektar Therapeutics Inc.) - P/E multiplikatori|Upstream Bio, Inc. (UPB) - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Zenas Biopharma, Inc. (ZBIO)|Narx-foyda koeffitsiyenti Immunome Bio IMNM|P/E multiplikatori GOSS (Gossamer Bio, Inc.)|kalvista.com - Narxning foydaga nisbati|SEPN: Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati PVLA (Pieris Pharma)|SVRA: P/E multiplikatori|RIGL (Rigel Corp) - Narxning foydaga nisbati|ANAB (AnaptysBio, Inc.) - P/E multiplikatori|astriatx.com (ATXS) - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati enGene (ENGN)|RAPT - Kapitalizatsiyaning foydaga nisbati|Aerovate Therapeutics - Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati ACRS|Kyverna Therapeutics - P/E multiplikatori|Biznesning o‘zini qoplash muddati tizianalifesciences.com TLSA|Cabaletta Bio (CABA) - Narxning foydaga nisbati|Narx-foyda multiplikatori VTYX|THTX (Theratechnologies Inc) - P/E multiplikatori|Narx-foyda koeffitsiyenti Avalo Therapeutics Inc (AVTX)|P/E multiplikatori ELDN|Narx-foyda koeffitsiyenti agenusbio.com AGEN|Narxning foydaga nisbati Zura Bio ZURA|aTyr Pharma Inc - Narxning foydaga nisbati|ADAG: Narx-foyda koeffitsiyenti|Kapitalizatsiyaning foydaga nisbati ImageneBio Inc|shattucklabs.com (STTK) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Equillium|Narxning foydaga nisbati Connect Biopharma Holdings|Immunic Inc - Kapitalizatsiyaning sof foydaga nisbati|P/E multiplikatori ATRA|IFRX (inflarx.de) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori XFOR (X4 Pharmaceuticals)|P/E multiplikatori Adicet Bio Inc. ACET|CELU - Narxning foydaga nisbati|Kompaniya qiymatining sof foydaga nisbati INMB (INmune Bio Inc)|Barinthus Bio (BRNS) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Kezar Life Sciences Inc|SABS (SAB Biotherapeutics) - P/E multiplikatori|P/E multiplikatori akaritx.com|Narx-foyda koeffitsiyenti ENLV (Enlivex Therapeutics)|QTTB (q32bio.com) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori GOVX (GeoVax Labs Inc)|Biznesning o‘zini qoplash muddati Edesa Biotech Corp (EDSA)|IBIO - Narxning foydaga nisbati|Carisma Therapeutics (CARM) - Narx-foyda koeffitsiyenti|XTL Biopharmaceuticals Ltd. (XTLB) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Bolt Biotherapeutics, Inc.|Narx-foyda koeffitsiyenti HCWB|P/E multiplikatori Aptevo|Narxning foydaga nisbati AIM ImmunoTech Inc. (AIM)|aditxt.com - Narx-foyda multiplikatori|P/E multiplikatori GRI (GRI Bio)|XORTX Therapeutics Inc (XRTX) - Kapitalizatsiyaning foydaga nisbati|ReShape Lifesciences - P/E multiplikatori|Revelation Biosciences Corp (REVB) - Narx-foyda koeffitsiyenti|Indaptus Therapeutics (INDP) - Narxning foydaga nisbati|SCNI (scinai.com) - Narxning foydaga nisbati|CALI (CalciMedica Inc) - P/E multiplikatori|Affimed Therapeutics (AFMD) - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Allakos Inc. (ALLK)|Narx-foyda koeffitsiyenti hookipapharma.com HOOK|P/E multiplikatori IGMS (IGM Biosciences)|iteostherapeutics.com - Narxning foydaga nisbati|OCEA: Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati TCBP (TC BioPharm (Holdings) Plc)|THRD: P/E multiplikatori
